STOCK TITAN

Clover Health (CLOV) exec sells 6,229 shares in mandated tax-withholding trade

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Clover Health Investments executive Jamie L. Reynoso, CEO of Medicare Advantage, reported an open-market sale of 6,229 shares of Class A Common Stock at $5.26 per share. After this transaction, Reynoso directly holds 2,834,982 shares.

According to the disclosure, the shares were sold solely to cover tax withholding obligations tied to the vesting of 6.25% of restricted stock units that vested on July 3, 2026. The RSUs were originally granted on January 3, 2023 and vest in equal 6.25% quarterly installments through a final vesting date on January 1, 2027, subject to continued service. The company states these sales are mandated under its equity incentive plans as “sell to cover” transactions and are not discretionary trades by Reynoso.

Positive

  • None.

Negative

  • None.
Insider Reynoso Jamie L.
Role CEO, Medicare Advantage
Sold 6,229 shs ($33K)
Type Security Shares Price Value
Sale Class A Common Stock 6,229 $5.26 $33K
Holdings After Transaction: Class A Common Stock — 2,834,982 shares (Direct)
Footnotes (1)
  1. F1. The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on July 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Shares sold 6,229 shares Open-market sale on July 6, 2026
Sale price $5.26 per share Price for Class A Common Stock sold
Shares held after sale 2,834,982 shares Direct holdings following the reported transaction
RSU vesting tranche 6.25% Portion of RSUs vesting each quarter
RSU grant date January 3, 2023 Original grant date of the RSUs
Final RSU vesting date January 1, 2027 Last scheduled vesting, subject to continued service
restricted stock units financial
"The sales reported on this Form 4 represent shares ... in connection with the vesting of 6.25% of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"shares of Class A Common Stock required to be sold ... to cover tax withholding obligations in connection with the vesting"
sell to cover financial
"funded by a "sell to cover" transaction and do not represent discretionary trades"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
equity incentive plans financial
"mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations"
Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did CLOV executive Jamie L. Reynoso report?

Jamie L. Reynoso reported selling 6,229 shares of Clover Health Class A Common Stock at $5.26 per share. The sale was linked to tax withholding for vesting restricted stock units and did not represent a discretionary, open-market portfolio decision.

Why did Jamie L. Reynoso sell Clover Health (CLOV) shares in this Form 4?

The shares were sold to satisfy tax withholding obligations from RSUs vesting on July 3, 2026. Clover Health’s equity plans require a “sell to cover” transaction for taxes, so the sale is characterized as mandated rather than an elective trade by Reynoso.

How many CLOV shares does Jamie L. Reynoso hold after this reported sale?

After selling 6,229 shares, Jamie L. Reynoso directly holds 2,834,982 shares of Clover Health Class A Common Stock. This filing indicates the transaction was relatively small compared with the remaining position, which continues to reflect a large direct shareholding.

What are the vesting terms of Jamie L. Reynoso’s Clover Health RSUs?

The RSUs were granted on January 3, 2023 and vest in equal 6.25% quarterly installments. Vesting runs through a final vesting date on January 1, 2027, conditioned on Reynoso’s continued service with Clover Health on each scheduled vesting date.

Do the CLOV share sales by Jamie L. Reynoso represent discretionary trading?

The company states the sales do not represent discretionary trading by Jamie L. Reynoso. They result from Clover Health’s election under its equity incentive plans to fund tax withholding obligations via mandated “sell to cover” transactions when restricted stock units vest.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Reynoso Jamie L.

(Last)(First)(Middle)
C/O CLOVER HEALTH INVESTMENTS, CORP.
NOT APPLICABLE

(Street)
WILMINGTON DELAWARE 19801

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CLOVER HEALTH INVESTMENTS, CORP. /DE [ CLOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CEO, Medicare Advantage
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock07/06/2026S(1)6,229D$5.262,834,982D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on July 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Remarks:
/s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)